Cargando…

Effects of radical cystectomy, radiotherapy, and chemotherapy on the risk of long-term heart-specific death in bladder cancer patients

BACKGROUND: At present, the low risk of bladder cancer (BCa)-specific death has allowed for investigation into treatment-related cardiotoxicity. To aid clinicians in selecting appropriate cardiovascular disease screening strategies and interventions, this study explored the heart-specific mortality...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Fuhan, Li, Cheng, Guo, Yadong, Yu, Yang, Mao, Shiyu, Wang, Ruiliang, Zhang, Wentao, Zhang, Aihong, Yao, Xudong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575595/ https://www.ncbi.nlm.nih.gov/pubmed/34804825 http://dx.doi.org/10.21037/tau-21-835

Ejemplares similares

Effects of Radiotherapy or Radical Prostatectomy on the Risk of Long-Term Heart-Specific Death in Patients With Prostate Cancer
por: Guo, Yadong, et al.
Publicado: (2020)

Association between perioperative glucocorticoids and cancer metastasis and survival in patients undergoing radical cystectomy for urothelial carcinoma of the bladder: A single-center retrospective study
por: Mao, Shiyu, et al.
Publicado: (2020)

Causes of Death after Prostate Cancer Diagnosis: A Population-Based Study
por: Guo, Yadong, et al.
Publicado: (2022)

Development of nomograms related to inﬂammatory biomarkers to estimate the prognosis of bladder cancer after radical cystectomy
por: Zhang, Wentao, et al.
Publicado: (2021)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
por: Guo, Yadong, et al.
Publicado: (2019)

Preoperative C-reactive protein/albumin ratio is a significant predictor of survival in bladder cancer patients after radical cystectomy: a retrospective study
por: Guo, Yadong, et al.
Publicado: (2018)

Comparison of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Bladder Cancer Patients Undergoing Radical Cystectomy
por: Wang, Ruiliang, et al.
Publicado: (2019)

Gender dimorphism in survival of patients with lymph node metastasis of bladder cancer
por: Guo, Yadong, et al.
Publicado: (2022)

Bladder cancer-associated microbiota: Recent advances and future perspectives
por: Zhang, Wentao, et al.
Publicado: (2023)

Evaluation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-confined Bladder Cancer
por: Guo, Yadong, et al.
Publicado: (2019)

CALD1 promotes the expression of PD-L1 in bladder cancer via the JAK/STAT signaling pathway
por: Li, Cheng, et al.
Publicado: (2021)

Recent Trends in the Incidence of Clear Cell Adenocarcinoma and Survival Outcomes: A SEER Analysis
por: Guo, Yadong, et al.
Publicado: (2022)

SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis
por: Huang, Jianhua, et al.
Publicado: (2021)

Sulfatase 2 Affects Polarization of M2 Macrophages through the IL-8/JAK2/STAT3 Pathway in Bladder Cancer
por: Zhang, Wentao, et al.
Publicado: (2022)

Overexpression of GAS6 Promotes Cell Proliferation and Invasion in Bladder Cancer by Activation of the PI3K/AKT Pathway
por: Mao, Shiyu, et al.
Publicado: (2020)

Overexpression of Indoleamine 2,3-Dioxygenase 1 Promotes Epithelial-Mesenchymal Transition by Activation of the IL-6/STAT3/PD-L1 Pathway in Bladder Cancer
por: Zhang, Wentao, et al.
Publicado: (2018)

Prognostic significance of red cell distribution width in bladder cancer
por: Ma, Wenchao, et al.
Publicado: (2020)

Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report
por: Mao, Shiyu, et al.
Publicado: (2019)

Pattern of Failure in Bladder Cancer Patients Treated with Radical Cystectomy: Rationale for Adjuvant Radiotherapy
por: Kim, Yong Bae, et al.
Publicado: (2010)

Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA
por: Mao, Shiyu, et al.
Publicado: (2021)

Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer
por: Fischer‐Valuck, Benjamin W., et al.
Publicado: (2019)

Prognostic Significance of Young Age and Non-Bone Metastasis at Diagnosis in Patients with Metastatic Prostate Cancer: a SEER Population-Based Data Analysis
por: Guo, Yadong, et al.
Publicado: (2019)

Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer
por: Zheng, Zongtai, et al.
Publicado: (2020)

MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1
por: Zhang, Wentao, et al.
Publicado: (2019)

Corrigendum: MicroRNA-153 decreases tryptophan catabolism and inhibits angiogenesis in bladder cancer by targeting indoleamine 2,3-dioxygenase 1
por: Zhang, Wentao, et al.
Publicado: (2023)

Singe intraoperative instillation of chemotherapy during radical cystectomy for bladder cancer: Oncological outcome and survival predictors
por: Yang, Jingtian, et al.
Publicado: (2023)

The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching study
por: Wahafu, Wasilijiang, et al.
Publicado: (2019)

Utilizing the Lactate Dehydrogenase-to-Albumin Ratio for Survival Prediction in Patients with Bladder Cancer After Radical Cystectomy
por: Xu, Hang, et al.
Publicado: (2023)

Extent of lymphadenectomy in radical cystectomy for bladder cancer
por: Ather, M Hammad, et al.
Publicado: (2005)

Editorial: Radical cystectomy in bladder cancer patients
por: Koshkin, Vadim S., et al.
Publicado: (2022)

A Genomic-Clinicopathologic Nomogram for the Prediction of Lymph Node Invasion in Prostate Cancer
por: Zheng, Zongtai, et al.
Publicado: (2021)

Cost-Effectiveness of Robot-Assisted Radical Cystectomy vs Open Radical Cystectomy for Patients With Bladder Cancer
por: Dixon, Simon, et al.
Publicado: (2023)

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer
por: Wang, Ruiliang, et al.
Publicado: (2021)

The timing of radical cystectomy following neoadjuvant chemotherapy
por: Ramakrishnan, Venkat M., et al.
Publicado: (2018)

Urological cancer organoids, patients' avatars for precision medicine: past, present and future
por: Chen, Haotian, et al.
Publicado: (2022)

The prognostic value of the systemic immune-inflammation index for patients with bladder cancer after radical cystectomy
por: Zhang, Shiyu, et al.
Publicado: (2022)

Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer
por: Pak, Sahyun, et al.
Publicado: (2019)

Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer
por: Wan, Fangning, et al.
Publicado: (2014)

Preoperative predictors of early death risk in bladder cancer patients treated with robot‐assisted radical cystectomy
por: Zhu, Zhaowei, et al.
Publicado: (2019)

Radical Cystectomy and Orthotopic Bladder Substitution Using Ileum
por: Park, Jinsung, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4qk4g5a3vk5kl16nab8d4fu33i